| answer text |
<p>As negotiations on the pandemic instrument are live and in their early stages,
we cannot comment on the details of the United Kingdom’s negotiating position. Driving
access to safe, affordable essential medical countermeasures is a key priority for
the UK in these negotiations, as is ensuring that measures incentivise innovation
to strengthen research and development. Officials are working with international partners
and non-state actors to ensure the instrument improves access to vaccines, drugs and
tests, while also supporting the life sciences sector.</p><p>We have also been clear
that the UK will not sign up to a pandemic instrument or any instrument that would
compromise the UK’s ability to make domestic decisions on national measures concerning
public health policy.</p>
|
 |
